These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33616854)

  • 21. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
    Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
    Yoo SH; Ock CY; Keam B; Park SJ; Kim TM; Kim JH; Jeon YK; Chung EJ; Kwon SK; Hah JH; Kwon TK; Jung KC; Kim DW; Wu HG; Sung MW; Heo DS
    Korean J Intern Med; 2019 Nov; 34(6):1313-1323. PubMed ID: 30428646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of high-risk human papillomavirus mRNA silver in situ hybridization diagnostic assay in oropharyngeal squamous cell carcinomas.
    Gale N; Poljak M; Volavšek M; Hošnjak L; Velkavrh D; Bolha L; Komloš KF; Strojan P; Aničin A; Zidar N
    Pathol Res Pract; 2021 Oct; 226():153585. PubMed ID: 34455364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
    Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
    J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    Lorenzatti Hiles G; Chang KP; Bellile EL; Wang CI; Yen WC; Goudsmit CM; Briggs HL; Thomas TB; Peters L; Afsari MA; Pinatti LM; Morris AC; Jawad N; Carey TE; Walline HM
    PLoS One; 2021; 16(4):e0250530. PubMed ID: 33891627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Snietura M; Brewczynski A; Kopec A; Rutkowski T
    Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
    Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
    Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
    Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
    Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.
    Bledsoe TJ; Noble AR; Hunter GK; Rybicki LA; Hoschar A; Chute DJ; Saxton JP; Greskovich JF; Adelstein DJ; Koyfman SA
    Radiat Oncol; 2013 Jul; 8():174. PubMed ID: 23837872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
    Vento SI; Jouhi L; Mohamed H; Haglund C; Mäkitie AA; Atula T; Hagström J; Mäkinen LK
    Virchows Arch; 2018 Jun; 472(6):975-981. PubMed ID: 29721609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials.
    Yakin M; Seo B; Hussaini H; Rich A; Hunter K
    Aust Dent J; 2019 Mar; 64(1):11-18. PubMed ID: 30238467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.